What does STOK company do? | Glauxie AI

Q: What does STOK company do?

Stoke Therapeutics, Inc. (STOK) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Ian F. Smith. Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United... Employees: 38,000.

Q: Who is the CEO of STOK?

Find out who leads STOK — CEO name, executive team, and compensation details.

Q: What sector is STOK in?

Find STOK sector, industry, and sub-industry classification with sector peer comparison.

Q: What are STOK competitors?

Compare STOK to its top competitors with side-by-side financials, valuation, and performance.

What does STOK company do?

🦉

Stoke Therapeutics, Inc. (STOK)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOIan F. Smith

Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design...

Key Executives

Name	Title
Adrian R. Krainer	Co-Founder & Independent Director
Barry S. Ticho FACC	Chief Medical Officer
Dawn Kalmar	Chief of Corporate Affairs & Strategic Partnerships
Doug Snow	Director of Communications & Investor Relations
Edward Kaye	Advisor & Director
Ian F. Smith	Chief Executive Officer & Director

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

STOK Profile Financials

Who is the CEO of STOK? What sector is STOK in? What are STOK competitors?